Square (SQ) PT Raised to $85 at Mizuho Securities

Square (SQ) PT Raised to $73 at Jefferies

Jefferies analyst John Hecht raised the price target on Square (NYSE: SQ) to $73.00 (from $64.00) while maintaining a Hold rating following results.

Citi Reiterates Buy on Square (SQ) Following Earnings Report

Citi analyst, Peter Christiansen, reiterated a Buy rating and $90.00 price target on Square (NYSE: SQ) following the company's earnings report. SQ delivered on the top-line with 64% Adj revenue growth ~3 points better than consensus expectations. EBITDA was 2-3% better, though slightly below margin estimates... More

Square (SQ) PT Rises At Jefferies On Improving Transaction Margins And Services Growth

Jefferies analyst, John Hecht, reiterated his Hold rating on shares of Square (NYSE: SQ) and raised his price target to $73 from $64 after the company reported robust top-line revenue of $464M, up 64% y/y and ahead of Street Consensus of $453M. This represents a slight... More

Square (SQ) PT Raised to $88 at RBC Capital

RBC Capital analyst Daniel Perlin raised the price target on Square (NYSE: SQ) to $88.00 (from $86.00) while maintaining a Outperform rating following solid results.

Perlin commented, "Square posted another solid quarter with subscriptions & services revenue increasing significantly y/y, transaction revenue & GPV growth slightly below 30%,... More

JPMorgan Looks Through Square's (SQ) Below Consensus Guide, Reit Overweight

JPMorgan analyst, Tien-tsin Huang, reiterated his Overweight rating on shares of Square (NYSE: SQ) after the company's financial results and outlook were strong despite high expectations. Revenue for 4Q grew 64% and KPIs remain very healthy, with Subscription and Services revenues up 144% y/y.... More

Square (SQ) PT Lowered to $100 at KeyBanc

KeyBanc analyst Josh Beck lowered the price target on Square (NYSE: SQ) to $100.00 (from $115.00) while maintaining a Overweight rating.

After-Hours Movers 02/27: (TTOO) (TWNK) (WBC) Higher; (BOX) (BKNG) (CELG) (more...)

Today's After-Hours Movers

T2 Biosystems, Inc. (NASDAQ: TTOO) 31.7% HIGHER; The FDA has granted T2 Biosystems, Inc. (NASDAQ: TTOO) Breakthrough Device designation for the T2Resistance Panel, a diagnostic panel that can detect 13 resistance genes from both gram-positive and gram-negative pathogens from a single patient blood sample, without the wait for blood culture.

Box (NYSE: BOX) 23.6% LOWER; reported Q4 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $163.7... More

Square (SQ) Reports In-Line Q4 EPS; Provides Mixed Outlook

Square (NYSE: SQ) reported Q4 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $464 million versus the consensus estimate of $454.1 million.

GUIDANCE:

Square sees Q1 2019 EPS of $0.06-$0.08, versus the consensus of $0.11. Square sees Q1... More